Literature DB >> 6392344

Insulin within islets is a physiologic glucagon release inhibitor.

H Maruyama, A Hisatomi, L Orci, G M Grodsky, R H Unger.   

Abstract

To determine if glucagon secretion is under physiological control of intra-islet insulin, pancreata from normal rats were perfused at a 100 mg/dl glucose concentration with either guinea pig antiinsulin serum or normal guinea pig serum in a nonrecirculating system. Perfusion of antiserum was followed within 3 min by a significant rise in glucagon that reached peak levels three times the base-line values and assumed a hectic pattern that returned rapidly to base-line levels upon termination of the antiserum perfusion. Nonimmune guinea pig serum had no effect. To gain insight into the probable site of insulin neutralization, 125I-labeled human gamma-globulin was added to antiserum or nonimmune serum and perfused for 3 min. More than 83% of the radioactivity was recovered in the effluent within 3 min after termination of the infusion, and only 0.05 +/- 0.015% of the radioactivity injected was present in the pancreas 10 min after the perfusion. The maximal amount of insulin that could be completely bound to insulin antibody at a dilution and under conditions simulating those of the perfusion experiments was 20 mU/min. It is concluded that insulin maintains an ongoing restraint upon alpha cell secretion and in its absence causes hectic hypersecretion of glucagon. This restraint probably occurs largely in the intravascular compartment. Loss of this release-inhibiting action of insulin may account for initiation of hyperglucagonemia in insulin-deficient states.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6392344      PMCID: PMC425424          DOI: 10.1172/JCI111658

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  14 in total

1.  The in vitro perfused pancreas.

Authors:  G M Grodsky; R E Fanska
Journal:  Methods Enzymol       Date:  1975       Impact factor: 1.600

2.  Immunoassay of endogenous plasma insulin in man.

Authors:  R S YALOW; S A BERSON
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

Review 3.  Pancreatic action of the sulfonylureas.

Authors:  G M Grodsky; G H Epstein; R Fanska; J H Karam
Journal:  Fed Proc       Date:  1977-12

4.  Insulin control of glucagon release from insulin-deficient rat islets.

Authors:  K D Buchanan; W A Mawhinney
Journal:  Diabetes       Date:  1973-11       Impact factor: 9.461

5.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

6.  In vivo inhibition of glucagon secretion by paracrine beta cell activity in man.

Authors:  C M Asplin; T L Paquette; J P Palmer
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

7.  The effect of experimental insulin deficiency on glucagon secretion.

Authors:  W A Müller; G R Faloona; R H Unger
Journal:  J Clin Invest       Date:  1971-09       Impact factor: 14.808

8.  Studies of pancreatic alpha cell function in normal and diabetic subjects.

Authors:  R H Unger; E Aguilar-Parada; W A Müller; A M Eisentraut
Journal:  J Clin Invest       Date:  1970-04       Impact factor: 14.808

9.  Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics.

Authors:  P Raskin; Y Fujita; R H Unger
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

10.  Effects of exogenous insulin, glucagon, and somatostatin on islet hormone secretion in the perfused chicken pancreas.

Authors:  R N Honey; M B Fallon; G C Weir
Journal:  Metabolism       Date:  1980-12       Impact factor: 8.694

View more
  107 in total

Review 1.  Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes.

Authors:  Philip E Cryer
Journal:  Endocrinology       Date:  2011-12-13       Impact factor: 4.736

2.  Involvement of alpha1 and beta-adrenoceptors in adrenaline stimulation of the glucagon-secreting mouse alpha-cell.

Authors:  Elaine Vieira; Yi-Jia Liu; Erik Gylfe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-01-15       Impact factor: 3.000

Review 3.  Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover.

Authors:  Roger H Unger; Alan D Cherrington
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

4.  Paracrine regulation of glucagon secretion: the β/α/δ model.

Authors:  Margaret Watts; Joon Ha; Ofer Kimchi; Arthur Sherman
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-02-02       Impact factor: 4.310

5.  Hyperglycemia in rodent models of type 2 diabetes requires insulin-resistant alpha cells.

Authors:  Young Lee; Eric D Berglund; Xinxin Yu; May-Yun Wang; Matthew R Evans; Philipp E Scherer; William L Holland; Maureen J Charron; Michael G Roth; Roger H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-25       Impact factor: 11.205

6.  Delayed onset of hyperglycaemia in a mouse model with impaired glucagon secretion demonstrates that dysregulated glucagon secretion promotes hyperglycaemia and type 2 diabetes.

Authors:  N Gustavsson; T Seah; Y Lao; G K Radda; T C Südhof; W Han
Journal:  Diabetologia       Date:  2010-10-27       Impact factor: 10.122

Review 7.  Motivations and methods for analyzing pulsatile hormone secretion.

Authors:  Johannes D Veldhuis; Daniel M Keenan; Steven M Pincus
Journal:  Endocr Rev       Date:  2008-10-21       Impact factor: 19.871

Review 8.  Paracrine signaling in islet function and survival.

Authors:  Sean M Hartig; Aaron R Cox
Journal:  J Mol Med (Berl)       Date:  2020-02-17       Impact factor: 4.599

9.  Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients.

Authors:  Ele Ferrannini; Elza Muscelli; Silvia Frascerra; Simona Baldi; Andrea Mari; Tim Heise; Uli C Broedl; Hans-Juergen Woerle
Journal:  J Clin Invest       Date:  2014-01-27       Impact factor: 14.808

10.  Glucagon gene transcription is negatively regulated by insulin in a hamster islet cell line.

Authors:  J Philippe
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.